Results 281 to 290 of about 14,066,519 (402)

Factors influencing engagement of at-risk individuals in cytomegalovirus vaccine clinical trials: insights from the USA [PDF]

Michael Penlington, Hannah Alsdurf, Heather VanSeggelen, Uwe Nicolay, Rebekah L. Scheuerle, Michel M Reid, Anil A. Panackal   +6 more
openalex   +1 more source

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

Clinical Infectious Diseases, 2017
P. Ljungman, M. Boeckh, H. Hirsch, F. Josephson, J. Lundgren, G. Nichols, A. Pikis, R. Razonable, V. Miller, P. Griffiths   +9 more
semanticscholar   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

Clinical Trials Rules [PDF]

European Heart Journal, 2017
openaire   +2 more sources

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Decentralized clinical trials: A comprehensive analysis of trends, technologies, and global challenges. [PDF]

PLOS Digit Health
Kijewski S, McBride C, Owens E, Bernheim E, Vayena E.   +4 more
europepmc   +1 more source

Integration Of Large Language Models Across The Clinical Trial Lifecycle: From Protocol Development To Regulatory Approval

Rajni Kant
openalex   +2 more sources

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

​Consideration of sex/gender aspects in cardiovascular clinical trials. [PDF]

Clin Res Cardiol
Bley M, Mathez L, Menz S, Stephan I, Regitz-Zagrosek V, Lerchenmueller MJ, Lerchenmüller C.   +6 more
europepmc   +1 more source